Specialty Pharmacy

Taking more than 5 medications was associated with fatigue and memory problems in multiple sclerosis patients, a new study reports.

Program offers choice and flexibility to improve the specialty patient experience and deliver superior health outcomes.

Independent Pharmacy Cooperative teams with Diplomat's retail specialty network.

The 2014 Kantar Media Pharmacy Readership Survey finds Pharmacy Times is the top choice among pharmacists, and the publication rated first in several key demographics.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses challenges for specialty pharmacy in the management of patients with multiple sclerosis.

Patients with HIV who smoke may be at even greater risk of developing smoking-related cancers.

Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses developments in the treatment of lung cancer that specialty pharmacies need to be aware of.

ACO focus on efficiency and quality metrics rather than pharmaceutical access cited in new survey.

Catamaran Corporation Senior Vice President of Pharmacy Operations and Industry Albert Thigpen discusses the impact from the high cost of specialty medications on overall drug spending in 2014.

Role of specialty pharmacies in treatment of multiple sclerosis discussed during annual Armada summit.

Emerging therapies and the role of specialty pharmacies in the treatment of non-small cell lung cancer were discussed during a continuing education session at the annual Armada summit.

Streamlining exon skipping drugs for other mutations will allow the company to reach over half of the Duchenne muscular dystrophy population.

CVS Caremark specialty pharmacy executive discusses the evolution of a patient-centered health care ecosystem.

CVS/pharmacy first to seek community pharmacy accreditation.

The cost of specialty drugs is driving increases in overall unit cost, according to an annual Catamaran Corporation report.

Study finds progeria treatment to extend survival time by 1.6 years.

Opexa Therapeutics is initiating a phase IIb trial of a novel therapy that targets T-cells in patients with secondary progressive multiple sclerosis.

Author and consultant Myrtle Potter told attendees of the Armada Specialty Pharmacy Summit that specialty pharmacies need to demonstrate their value to capitalize on the changing health care environment.

An analysis of several phase III clinical trials suggests that health-related quality-of-life scores decrease less when patients receive sofosbuvir therapy than interferon therapy.

The cooperative meeting of CMSC and ACTRIMS in Dallas platforms latest treatment, research and resources for MS health care professionals.

Using Captisol technology, scientists have developed a more stable formulation of melphalan that may facilitate higher-intensity regimens in patients with multiple myeloma undergoing autologous stem cell transplant procedures.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Research suggests salaried physicians practice in the same manner as those reimbursed by fee-for-service methodology.

Thousands of stakeholders assemble to discuss issues and growth in specialty pharmacy.

Armada Health Care celebrates the 10th anniversary of its annual specialty pharmacy conference.

A study suggests that patients with ankylosing spondylitis and psoriatic arthritis have more cardiac risk factors than age- and gender-matched controls.

A variety of treatments to counteract the bone-wasting effects of multiple myeloma are in development.

A large epidemiologic study in Baltimore and Philadelphia shows that patients with mental illness are 4 times more likely to have HIV infection than the general population. Results of this study reveal a need for routine HIV screening in mental health facilities.

Innovative new specialty drugs helped push total drug spending to $329.2 billion in 2013.